Gilead Sciences earnings were -$3.9B for the trailing 12 months ending Sep 30, 2026, with N/A growth year over year. The latest GILD earnings report on Sep 30, 2026 announced Q3 2026 earnings of $2.4B, down 123.1% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, GILD reported annual earnings of $8.5B, with 1,672.9% growth.
What were Gilead Sciences's earnings last quarter?
On GILD's earnings call on Oct 29, 2026, Gilead Sciences (NASDAQ: GILD) reported Q3 2026 earnings per share (EPS) of $1.96, up 20.33% year over year. Total GILD earnings for the quarter were $2.43 billion. In the same quarter last year, Gilead Sciences's earnings per share (EPS) was $2.46.
As of the last Gilead Sciences earnings report, Gilead Sciences is currently losing money. Gilead Sciences's net profit (also called net income) for the twelve months ending Sep 30, 2026 was -$3.86 billion, a 147.63% decrease year over year.
What was GILD's earnings growth in the past year?
As of Gilead Sciences's earnings date in Oct 29, 2026, Gilead Sciences's earnings has grown year over year. GILD earnings in the past year totalled -$3.86 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.